A study on biochemically recurrent PCa estimated that PSMA-PET imaging could reduce 75 PCa deaths per 1000 patients, increase life years by 988, and add 824 quality-adjusted life years compared to conventional imaging (4). The gene discussed is FOLH1; the disease is posterior cortical atrophy.